Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 41, Issue 7, 1998, Pages 1241-1250

  Herrmann, Martin ^a   Voll, Reinhard E ^a   Zoller, Otmar M ^a   Hagenhofer, Manuela ^a   Ponner, Botond B ^a   Kalden, Joachim R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE COMPLEX DISEASE; INFLAMMATION; MACROPHAGE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANNEXIN A5; APOPTOSIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; PHAGOCYTOSIS;

EID: 0031838606     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H     Document Type: Article

References (86)

1. Haas M. IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies. Am J Kidney Dis 1994;23:358-64.
2. Koutouzov S, Cabrespines A, Amoura Z, Chabre H, Lotton C, Bach JF. Binding of nucleosomes to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies. Eur J Immunol 1996;26:472-86.
3. Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum 1996;39:894-903.
4. Morioka T, Woitas R, Fujigaki Y, Batsford SR, Vogt A. Histone mediates glomerular deposition of small size DNA anti-DNA complex. Kidney Int 1994;45:991-7.
5. D'Cruz DP, Houssiau FA, Ramirez G, Baguley E, McCutcheon J, Vianna J, et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol 1991;85:254-61.
6. Harigai M, Hara M, Takahashi N, Kitani A, Hirose T, Suzuki K, et al. Presence of autoantibodies to peptidyl-prolyl cis-trans isomerase (cyclosporin A-binding protein) in systemic lupus erythematosus. Clin Immunol Immunopathol 1992;63:58-65.
7. Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus: prevalence, specificities, and clinical significance. Arthritis Rheum 1995;38:633-7.
8. Brand SR, Bernstein RM, Mathews MB. Autoreactive epitope profiles of the proliferating cell nuclear antigen define two classes of autoantibodies. J Immunol 1994;152:4120-8.
9. Brito J, Biamonti G, Caporali R, Montecucco C. Autoantibodies to human nuclear lamin B2 protein: epitope specificity in different autoimmune diseases. J Immunol 1994;153:2268-77.
10. Hoet RM, Kastner B, Luhrmann R, van Venrooij WJ. Purification and characterization of human autoantibodies directed to specific regions on U1RNA; recognition of native U1RNP complexes. Nucleic Acids Res 1993;21:5130-6.
11. Reichlin M, Martin A, Taylor Albert E, Tsuzaka K, Zhang W, Reichlin MW, et al. Lupus autoantibodies to native DNA cross-react with the A and D snRNP polypeptides. J Clin Invest 1994;93:443-9.
12. Barbas SM, Ditzel HJ, Salonen EM, Yang WP, Silverman GJ, Burton DR. Human autoantibody recognition of DNA. Proc Natl Acad Sci U S A 1995;92:2529-33.
13. Van Es JH, Gmelig Meyling FH, van de Akker WR, Aanstoot H, Derksen RH, Logtenberg T. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J Exp Med 1991;173:461-70.
14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
15. Shan H, Shlomchik MJ, Marshak Rothstein A, Pisetsky DS, Litwin S, Weigert MG. The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J Immunol 1994;153:5104-20.
16. Winkler TH, Fehr H, Kalden JR. Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur J Immunol 1992;22:1719-28.
17. Winkler TH, Jahn S, Kalden JR. IgG human monoclonal anti-DNA autoantibodies from patients with systemic lupus erythematosus. Clin Exp Immunol 1991;85:379-85.
18. Reichlin M, Harley JB, Lockshin MD. Serologic studies of monozygotic twins with systemic lupus erythematosus. Arthritis Rheum 1992;35:457-64.
19. Hartung K, Baur MP, Coldewey R, Fricke M, Kalden JR, Lakomek HJ, et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus: results of a multicenter study. J Clin Invest 1992;90:1346-51.
20. De Juan D, Martin Villa JM, Gomez Reino JJ, Vicario JL, Corell A, Martinez Laso J, et al. Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility. Hum Genet 1993;91:579-84.
21. Witte T, Dumoulin FL, Gessner JE, Schubert J, Gotze O, Neumann C, et al. Defect of a complement receptor 3 epitope in a patient with systemic lupus erythematosus. J Clin Invest 1993;92: 1181-7.
22. Tsai YT, Chiang BL, Kao YF, Hsieh KH. Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus. Int Arch Allergy Immunol 1995;106:235-40.
23. Krieg AM. CpG DNA: a pathogenic factor in systemic lupus erythematosus? J Clin Immunol 1995;15:284-92.
24. Golan TD, Elkon KB, Gharavi AE, Krueger JG. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 1992;90:1067-76.
25. Rihner M, McGrath HJ Jr. Fluorescent light photosensitivity in patients with systemic lupus erythematosus. Arthritis Rheum 1992;35:949-52.
26. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 1994;37:1415-20.
27. Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH, et al. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 1994;93:1029-34.
28. Amasaki Y, Kobayashi S, Takeda T, Ogura N, Jodo S, Nakabayashi T, et al. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clin Exp Immunol 1995;99:245-50.
29. Oishi M, Maeda K, Sugiyama S. Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines. Arch Dermatol Res 1994;286:396-407.
30. Canale VC, Smith CH. Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr 1967;70:891-9.
31. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935-46.
32. Rieux Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268: 1347-9.
33. Sneller MC, Straus SE, Jaffe ES, Jaffe JS, Fleisher TA, Stetler Stevenson M, et al. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 1992; 90:334-41.
34. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994;152:3685-92.
35. Lorenz H-M, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997;40:306-17.
36. Kalden JR, Winkler TH, Herrmann M, Krapf F. Pathogenesis of SLE: immunopathology in man. Rheumatol Int 1991;11:95-100.
37. Casciola Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179:1317-30.
38. Casciola Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A 1996;93:1624-9.
39. Rosen A, Casciola Rosen L, Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 1995;181: 1557-61.
40. Desai Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 1995;95:531-41.
41. Voll RE, Roth E, Herrmann M, Fehr H, Girkontaite I, Lorenz H-M, et al. Histone-specific Th clones derived from systemic lupus erythematosus patients display a ThO- or Th1-like cytokine secretion pattern [abstract]. Arthritis Rheum 1996;39 Suppl 9:S249.
42. Akbar AN, Savill J, Gombert W, Bofill M, Borthwick NJ, Whitelaw F, et al. The specific recognition by macrophages of CD8+,CD45RO+ T cells undergoing apoptosis: a mechanism for T cell clearance during resolution of viral infections. J Exp Med 1994;180:1943-7.
43. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992;149: 4029-35.
44. Haslett C, Savill J, Meagher L. Macrophage recognition of senescent granulocytes. Biochem Soc Trans 1990;18:225-7.
45. Haslett C, Savill JS, Whyte MK, Stern M, Dransfield I, Meagher LC. Granulocyte apoptosis and the control of inflammation. Philos Trans R Soc Lond B Biol Sci 1994;345:327-33.
46. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989;83:865-75.
47. Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990;343:170-3.
48. Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992;90:1513-22.
49. Hall SE, Savill JS, Henson PM, Haslett C. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J Immunol 1994;153:3218-27.
50. Ren Y, Silverstein RL, Allen J, Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995;181:1857-62.
51. Ren Y, Savill J. Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J Immunol 1995;154:2366-74.
52. Sambrano GR, Steinberg D. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci U S A 1995;92:1396-400.
53. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994;372:100-3.
54. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995;182:1597-601.
55. Schwartz RS, Tanaka Y, Fidler IJ, Chiu DT, Lubin B, Schroit AJ. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest 1985;75:1965-72.
56. Baruch DI, Gormely JA, Ma C, Howard RJ, Pasloske BL. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1996;93:3497-502.
57. Voll RE, Herrmann M, Girkontaite I, Roth EA, Stach C, Kalden JR. Anti-inflammatory and immunoregulatory properties of apoptotic cells. Nature 1998;390:350-1.
58. Fadok VA, Laszlo DJ, Noble PW, Weinstein L, Riches DW, Henson PM. Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. J Immunol 1993;151:4274-85.
59. Bennett MR, Gibson DF, Schwartz SM, Tait JF. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 1995;77:1136-42.
60. Hughes J, Liu Y, van Damme J, Savill J. Human glomerular mesangial cell phagocytosis of apoptotic neutrophils: mediation by a novel CD36-independent vitronectin receptor/thrombospondin recognition mechanism that is uncoupled from chemokine secretion. J Immunol 1997;158:4389-97.
61. Brandt L, Hedberg H. Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosus. Scand J Haematol 1969;6:348-53.
62. Landry M. Phagocyte function and cell-mediated immunity in systemic lupus erythematosus. Arch Dermatol 1977;113:147-54.
63. Svensson BO. Serum factors causing impaired macrophage function in systemic lupus erythematosus. Scand J Immunol 1975;4: 145-50.
64. Vazquez Doval J, Sanchez Ibarrola A. Defective mononuclear phagocyte function in systemic lupus erythematosus: relationship of FcRII (CD32) with intermediate cytoskeletal filaments. J Investig Allergol Clin Immunol 1993;3:86-91.
65. Zurier RB. Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus. Arthritis Rheum 1976;19:73-8.
66. Kimberly RP, Meryhew NL, Runquist OA. Mononuclear phagocyte function in SLE. I. Bipartite Fc- and complement-dependent dysfunction. J Immunol 1986;137:91-6.
67. Capsoni F, Minonzio F, Ongari AM, Carbonelli V, Galli A, Zanussi C. IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-gamma. J Leukoc Biol 1995;58: 351-8.
68. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992;10:541-7.
69. Meagher LC, Savill JS, Baker A, Fuller RW, Haslett C. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J Leukoc Biol 1992;52:269-73.
70. Falasca L, Bergamini A, Scrafino A, Balabaud C, Dini L. Human Kupffer cell recognition and phagocytosis of apoptotic peripheral blood lymphocytes. Exp Cell Res 1996;224:152-62.
71. Hart SP, Dougherty GJ, Haslett C, Dransfield I. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes by human macrophages. J Immunol 1997;159:919-25.
72. Kiertscher SM, Roth MD. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leukoc Biol 1996;59:208-18.
73. Akagawa KS, Takasuka N, Nozaki Y, Komuro I, Azuma M, Ueda M, et al. Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 1996;88:4029-39.
74. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
75. Flora PK, Gregory CD. Recognition of apoptotic cells by human macrophages: inhibition by a monocyte/macrophage-specific monoclonal antibody. Eur J Immunol 1994;24:2625-32.
76. Tandon NN, Rock G, Jamieson GA. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura. Br J Haematol 1994;88: 816-25.
77. Rock G, Chauhan K, Jamieson GA, Tandon NN. Anti-CD36 antibodies in patients with lupus anticoagulant and thrombotic complications. Br J Haematol 1994;88:878-80.
78. Al-shahi R, Mason JC, Rao R, Hurd C, Thompson EM, Haskard DO, et al. Systemic lupus erythematosus, thrombocytopenia, microangiopathic haemolytic anemia and anti-CD36 antibodies. Br J Rheumatol 1997;36:794-8.
79. Casciola Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995;182:1625-34.
80. Casciola Rosen LA, Miller DK, Anhalt GJ, Rosen A. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994;269:30757-60.
81. Casciola Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, et al. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996;183:1957-64.
82. Casiano CA, Martin SJ, Green DR, Tan EM. Selective cleavage of nuclear autoantigens during CD95 (Fas/Apo-19)-mediated T cell apoptosis. J Exp Med 1996;184:765-70.
83. Deng H, Apple R, Clare-Salzler M, Trembleau S, Mathis D. Adorini L, et al. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med 1993;178:1675-80.
84. Mamula MJ, Lin RH, Janeway CA, Hardin JA. Breaking T cell tolerance with foreign and self co-immunogens: a study of autoimmune B and T cell epitopes of cytochrome c. J Immunol 1992;149:789-96.
85. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-7.
86. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: major immunogen for pathogenic autoantibody inducing T cells of lupus. J Exp Med 1993;177:1367-81.